Stine Ulrik Mikkelsen
PhD Student
Grønbæk Group
Københavns Universitet, BRIC, Ole Maaløes Vej 5
2200 København N
ORCID: 0000-0003-2104-9201
1 - 5 out of 5Page size: 10
- 2023
- Published
LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
Kaastrup, K., Gillberg, Linn, Mikkelsen, Stine Ulrik, mxz703, mxz703, Schöllkopf, C., Mortensen, B. K., Porse, Bo Torben, Hansen, Jakob Werner & Grønbæk, Kirsten, 2023, In: Clinical Epigenetics. 15, 13 p., 91.Research output: Contribution to journal › Journal article › Research › peer-review
- 2021
- Published
Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance
Mikkelsen, Stine Ulrik, Safavi, S., Dimopoulos, K., O'Rourke, Colm, Andersen, M. K., Holm, M. S., Marcher, C. W., Andersen, Jesper Bøje, Hansen, Jakob Werner & Grønbæk, Kirsten, 2021, In: Haematologica. 106, 6Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
The role of vitamin C in epigenetic cancer therapy
Mikkelsen, Stine Ulrik, Gillberg, Linn, Lykkesfeldt, Jens & Grønbæk, Kirsten, 2021, In: Free Radical Biology and Medicine. 170, p. 179-193 15 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2020
- Published
Ruxolitinib and interferon-alpha 2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
Sorensen, A. L., Mikkelsen, Stine Ulrik, Knudsen, T. A., Bjorn, M. E., Andersen, Christen Bertel L, Bjerrum, O. W., Brochmann, N., Patel, D. A., Gjerdrum, Lise Mette Rahbek, El Fassi, D., Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, Claus Henrik, Ellervik, Christina, Pallisgaard, N., Thomassen, M., Kjaer, L., Skov, V. & Hasselbach, H. C., 2020, In: Haematologica. 105, 9, p. 2262-2272 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2018
- Published
Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis
Mikkelsen, Stine Ulrik, Kjaer, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Andersen, Christen Bertel L, Bjerrum, O. W., Brochmann, N., Fassi, Daniel El , Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, Claus Henrik, Pallisgaard, N., Thomassen, M., Skov, V. & Hasselbalch, Hans Carl, Aug 2018, In: Cancer Medicine. 7, 8, p. 3571-3581 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 180811652
Most downloads
-
105
downloads
Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
25
downloads
Ruxolitinib and interferon-alpha 2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
Research output: Contribution to journal › Journal article › Research › peer-review
Published